Mathieu Pernot received an engineering degree from ESPCI, Paris, France, in 2001, and the Ph.D. degree in physics from the Paris 7 University, in 2004. He is currently research director at the French National Institute of Health and Medical Research (INSERM) and the deputy director of Physics for Medicine Paris at the ESPCI, Paris, France. His main research activities focus on the development of wave physics for biomedical imaging and therapy including ultrafast ultrasound imaging in cardiology, neuroscience and therapeutic ultrasound. He has received several awards for his research including the Robert’s Prize, the Rotblat Medal and the Ile-de-France innovator prize. In 2012, he received a prestigious award from the European Research Council (ERC starting grant) for his research on ultrafast imaging of the human heart and early diagnosis of heart failure. In 2014, he co-founded Cardiawave, a French startup company to develop the first clinical ultrasound device for non-invasive therapy of aortic calcific valves. In 2017, he co-founded Iconeus to commercialize the first functional ultrasound imaging system for neuroscience. In 2022, he co-founded, eMyoSound to develop the first diagnostic device for non-invasive assessment of myocardial stiffness.
